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Abstract
Periodontal medicine is a broad term commonly used to define the relationship 
between periodontitis and systemic health. Periodontitis is a highly prevalent, 
chronic multifactorial infectious disease, induced by the dysbiotic biofilm that 
triggers a persistent systemic inflammation and recurrent bacteremia. There is 
a growing body of scientific evidence that suggests the potential implication of 
periodontitis in the causation and progression of various systemic disease and 
conditions, such as diabetes, cardiovascular disease, pulmonary disease, adverse 
pregnancy outcomes and cancer. Some studies consider periodontitis as an indepen-
dent risk factor for preterm birth, growth restriction, low birth-weight and pre-
eclampsia. However not all studies support the association. Despite sparse scientific 
data, some studies indicate that individuals with periodontitis are at increased risk 
for cancer development, due to the increased inflammatory burden sustained by the 
presence of periodontal pathogens. This chapter emphasis the relationship between 
periodontitis and adverse pregnancy outcomes and the underlying mechanisms that 
link peridontitis to oral carcinogenesis.
Keywords: periodontitis, periodontal medicine, adverse pregnancy outcomes, 
preterm birth, malignancy, carcinogenesis, head, neck squamous cell carcinoma
1. Introduction
1.1 Periodontitis - overview
Periodontitis is a chronic disease, determined by the dysbiotic biofilm that does 
not merely affect the oral cavity, but also impacts the systemic health by triggering a 
persistent low-grade, systemic inflammation and recurrent bacteriemia. Its clinical 
consequences, especially in extended and severe forms, impair the overall quality of 
life of the individuals.
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Significant progress has been made in determining the relationship between 
periodontitis and various systemic diseases. Some researchers consider peri-
odontitis as an independent risk factor that mediates the development and even 
progression of certain systemic disease. Conversely, specific systemic diseases and 
conditions have a negative impact on the periodontium and can even interfere 
with periodontitis’ progression. Valuable information are available with respect to 
several mechanisms underlying the correlation between periodontitis and systemic 
conditions. However, there are still plenty of issues, for which the scientific litera-
ture cannot currently provide specific answers, emphasizing their complexity and 
the need for further research in this area of interest.
1.2 Information search strategy and article selection
We conducted a search on the electronic database MEDLINE (PubMed) using 
MeSH terms and key words to identify relevant studies published between January 
2011 and November 2020. One search strategy included the following subject terms 
combination: ([“periodontitis”] OR [“periodontal disease”]) AND ([“pregnancy 
outcome”) OR [“preterm delivery”] OR [“birth weight”] OR [“pre-eclampsia”]). 
We searched another set of keywords as follows: ([“periodontitis”]) OR [“peri-
odontal disease”]) AND ([“microbiota”] OR [“porphyromonas gingivalis”]) AND 
([“squamous cell carcinoma of head and neck”] OR [“head and neck neoplasms”] 
OR [“oropharyngeal neoplasms”] OR [“oral squamous cell carcinoma”] OR [“mouth 
neoplasms”]). Filters used were: Humans and English. A hand-search was also 
conducted to identify any additional related articles in Journal of Periodontology, 
Journal of Clinical Periodontology, and on the EFP Official Website/Gum disease 
& General Health Resources. Further articles of interest were searched based on 
reference lists of the publications where papers were available online. The presence 
of duplicates was assessed through Zotero version 5.0.93 software.
2. The periodontal medicine concept
Periodontitis is a highly prevalent, chronic multifactorial infectious disease, 
induced by the subgingival dysbiotic biofilm that produces a local immune-
inflammatory response leading to the destruction of periodontal tissues. Its clinical 
manifestation, especially in extended and severe forms, impairs the overall quality 
of life, by affecting the psychosomatic, social and functional aspects of the indi-
viduals. Periodontitis also impacts the systemic health by triggering a persistent 
low-grade, systemic inflammation and recurrent bacteremia [1–4].
The concept of periodontal medicine was first introduced by Offenbacher [5]. 
Periodontal medicine is a broad term that describes an emerging branch of peri-
odontology exploring the two way relationship between periodontal and systemic 
status, as well as new diagnostic tools and advanced treatment approaches that take 
into consideration the link between periodontitis and various systemic diseases [5]. 
Current evidence suggests that periodontitis acts as a biologically plausible risk factor 
for the development and progression of other chronic, inflammatory diseases [4].
Some associations between periodontitis and certain systemic conditions, such 
as diabetes mellitus, cardiovascular disease, and adverse pregnancy outcomes have 
been reported [6, 7]. However, there is still inconsistent information on the associa-
tion between periodontitis and other systemic pathologies such as cancers, chronic 
renal disease, chronic obstructive pulmonary disease, minor cognitive impairment, 
rheumatoid arthritis, metabolic syndrome, and obesity [7, 8]. Contrarily, certain 
systemic diseases and conditions directly affect or worsen the periodontal status [9].
3
Periodontal Medicine: Impact of Periodontal Status on Pregnancy Outcomes and Carcinogenesis
DOI: http://dx.doi.org/10.5772/intechopen.96147
Establishing the potential causal relationship between periodontitis and chronic 
inflammatory systemic diseases and conditions is a difficult task, because complex 
pathologic conditions are the consequence of multiple exposures and broad inter-
actions of external and host-derived factors that modulate disease initiation and 
development [1].
Noncommunicable diseases account for seven of ten worldwide deaths. In 2016, 
approximately 71% of the 56.9 million worldwide deaths were due to noncom-
municable diseases and around 80% were due to cancers, cardiovascular diseases, 
chronic respiratory diseases and diabetes [10]. Since periodontitis is a potential, 
independent risk factor for many of these diseases, further investigations might 
bring additional benefits in improving the overall health status of the population 
and downsizing the socioeconomic burden at the same time.
3. Pathophysiological link between periodontitis and systemic diseases
Today there is increasing recognition that inflammation is a common molecular 
pathway that underlies the pathogenesis of diverse human diseases, ranging from 
infection to immune-mediated disorders, cardiovascular pathology, diabetes, 
metabolic syndrome, neurodegeneration, and cancer. Two pathogenic mechanisms 
might be involved in the activation of the pathways driving to development of 
pathologies at distant sites [11, 12].
The direct mechanism relies on the translocation of periodontal pathogens via 
systemic blood circulation, causing colonization and inflammation at a distance from 
the diseased periodontium. This mechanism corresponds to the concept of the “mobile 
oral microbiome” [13]. Moderate and severe periodontitis are characterized by deep 
periodontal pockets, with an ulcerated internal gingival epithelium, providing direct 
access for periodontal pathogens and their toxic by-products into the blood flow [12, 14]. 
Periodontal treatment, as well as daily tooth brushing cause episodic injuries to the peri-
odontal tissues, which further leads to recurrent, transient bacteremia and endotoxin-
emia [11, 14]. On the other hand, bacterial and endotoxin dissemination may be enabled 
by macrophages and dendritic cells, serving as carriers for the pathogens [13, 15].
The indirect mechanism is defined by the systemic inflammatory response 
towards periodontal pathogens or as a result of metastatic periodontal inflamma-
tion [12, 13]. Systemic dissemination of periodontal pathogens triggers the activa-
tion of acute phase proteins in the liver, which amplify the systemic inflammatory 
response in order to provide protection against the bacterial threat. Acute phase 
protein production and the following events, as a response to periodontal infection, 
may affect the physiological functionality of other organs and systems. Moreover, 
cytokines play critical roles in orchestrating the effective immune response of 
leukocytes and parenchymal cells towards systemic bacteremia. Leukocytes are 
the major source of innate cytokine responses. A healthy immune system has the 
capacity to effectively eliminate pathogens and restore homeostasis. However, a 
dysfunctional immune response and an ineffective clearance will eventually lead to 
the initiation and progression of inflammatory diseases [11, 13, 14].
4. The relationship between periodontitis and pregnancy outcomes
4.1 The influence of hormonal variations in pregnancy on the periodontium
Pregnancy is characterized by significant fluctuations in the levels of proges-
terone and estrogen hormones reaching up to 30 times higher plasma levels, by 
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the end of the third trimester. Various types of periodontal cells display receptors 
for these hormones [16, 17], which could explain the functional changes in the 
periodontal cells consecutive to fluctuating hormone levels during gestation, as 
well as microcirculatory system alterations [18]. These modifications are triggering 
an increased periodontal inflammatory manifestation, even in the presence of low 
levels of dental plaque, especially in the second and third trimesters of pregnancy. 
A gradual decrease of inflammatory manifestations after parturition has been 
reported [16–18].
Major alterations in the maternal immune system occur during pregnancy, 
which could favor periodontal infection and consecutive inflammation. Pregnant 
women have a reduction in phagocytosis and bactericidal activities of peripheral 
neutrophils and changes in the monocytes stimulated secretion of proinflammatory 
mediators after the contact with bacterial endotoxines [16].
Pregnancy not only impacts periodontal inflammation and host immune 
response, but also induces an increase in the oral microbial load and modifications 
in the oral microbiological profiles, as a consequence of elevated levels of steroid 
hormones [16, 18]. Significant changes in the subgingival microbiota with increases 
in the proportion of some periodontal pathogens such as Bacteroides melaninogeni-
cus, Prevotella intermedia, and Porphyromonas gingivalis have been described [16].
Pregnancy increases the risk of new-onset periodontal disease, but it can also 
activate preexisting periodontitis leading to an infectious and inflammatory load 
similar to new-onset periodontitis. Maternal periodontitis may reflect an intrinsic 
inflammatory or innate immunity trait that places the woman at risk for severe 
forms of periodontal disease, as well as for the common terminal biochemical 
inflammatory cascade associated with adverse pregnancy outcomes [19].
4.2  Epidemiological associations between periodontitis and adverse pregnancy 
outcomes
Many studies have associated adverse pregnancy outcomes, such as low birth 
weight, preterm birth and preeclampsia, with maternal periodontitis. The first 
case–control study referring to the relationship between periodontitis and preterm-
birth reported a 7.5 higher risk ratio for preterm births for the group of women with 
periodontitis as compared to the periodontal healthy control group [19]. Other 
studies have indicated oral maternal infections, including chronic periodontitis, 
as potential independent risk factors for various complications throughout the 
pregnancy. A systematic review including case–control, cohort case-control and 
controlled trials, confirmed the positive association between periodontitis and 
adverse pregnancy outcomes [20]. A meta-analysis reported a significant associa-
tion between periodontitis and preterm birth, with an odds ratio of 1.38 [21]. A 
more recent meta-analyses including 10.215 women, indicates that periodontitis 
doubles the risk for preterm delivery, the calculated odds ratio being of 2.01 (95% 
CI 1.71–2.36) [22]. However, the level of association is mostly modest, mainly due 
to the high degree of heterogeneity between the studies, particularly with respect to 
the diversity of periodontitis disease case definitions [23].
The relationship between periodontitis and adverse pregnancy outcomes was 
investigated also by means of surrogate markers defining both conditions. Many 
studies indicate a positive association between gingival crevicular fluid, inflamma-
tory mediators and adverse pregnancy outcomes [23, 24].
An umbrella review which analyzed systematic reviews and meta-analysis 
showed that non-surgical periodontal therapy with or without antibiotic therapy 
has low to moderate positive effects on reducing the frequency of the common 
pregnancy complications related to periodontitis [25]. The large heterogeneity of 
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the outcomes of the interventional studies is due to variations in periodontitis case 
definition, sample particularities, follow-up period, control of confounding factors, 
as well as the therapy moment throughout the pregnancy [14, 25]. The nonsurgical 
periodontal therapy may be ineffective in reducing inflammatory cascade once 
activated and thus eventually lead to preterm birth [14].
4.3 Medical impact of adverse pregnancy outcomes
Preterm birth is defined as the birth prior to 37 weeks of gestation [26]. 
Complications of preterm birth are a leading cause of infant deaths worldwide 
raising the neonatal mortality risk rate up to 11.4 [27, 28]. The prevalence of 
preterm birth ranges from 5 to 7% in high-income countries, and is generally 
higher in low-income ones [29]. In 2014, the estimated global preterm birth rate 
was 10.6%, the equivalent of about 14.84 million preterm births from a total 
number of 139.95 million livebirths [30]. Therefore, prematurity is considered a 
major public health issue and the identification of any potential risk factor is of 
tremendous importance [27, 28, 30].
Low birth weight is defined as a birth weight below 2500 g regardless of ges-
tational age of live infants [31, 32]. Various maternal factors such as extremes of 
maternal age, multiple pregnancies, obstetric complications, chronic maternal 
conditions like hypertensive disorders, and nutritional status or environmental 
exposures such as tobacco and drug use, can contribute to the low birth weight of 
the neonate. The estimates rate of global low birth weight for 2015 was 14.6% [31].
Maternal mortality is another important adverse outcome during pregnancy and 
is considered the death of a woman during pregnancy, within 42 days post-partum 
or during an abortion, as a consequence of any pregnancy associated pathologi-
cal condition or complication [33]. The yearly number of global maternal deaths 
decreased from 532.000 in 1990, to 303.000 in 2015 [34]. Between 1990 and 2015, 
10.7 million women worldwide died from various causes related to the evolution 
of pregnancy. Among the main risk factors of maternal mortality, pre-eclampsia 
and eclampsia are still in leading positions. Strategies aiming to reduce the number 
of deaths related to eclampsia showed a relatively low efficacy, which indicates the 
need to turn the attention to other potential risk factors in order to significantly 
lower mortality rates associated to eclampsia [33].
4.4  Pathophysiological link between periodontitis and adverse pregnancy 
outcomes
Hematogenous dissemination of periodontal bacteria is suspected to cause 
adverse pregnancy outcomes, by genitourinary tract and fetal–maternal unit 
colonization [16, 35]. Recent research indicates the presence of bacteria derived 
from supra- and subgingival biofilms in the placental microbiome. Moreover, some 
studies suggest that placental microbial profiles are closer to the oral microbial 
profiles than to the gut microbiome [36–38]. However, there is no general agree-
ment on the bacterial translocation concept. The presence of oral bacteria in the 
placenta could be the consequence of an external contamination [39].
Although maternal infection is considered a major contributor of adverse 
pregnancy outcomes, a critical factor which can trigger the preterm birth might 
be rather the persistent inflammation generated by chronic periodontal infec-
tions. Inflammatory mediators that are abundantly produced at the affected sites 
determine periodontal tissue breakdown [14]. From a clinical point of view, deep 
periodontal pockets indicate the magnitude of the periodontal inflammation [39]. 
Chronic, long-term periodontal inflammation will eventually lead to a continuous 
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passage of cytokines, chemokines, and gingival-derived C-reactive protein from the 
affected periodontal tissues into the bloodstream inducing a systemic acute-phase 
reaction and also maintaining a chronic, systemic inflammatory status [11, 12, 14]. 
High levels of C reactive protein over longer periods of time increases the risk for 
premature birth, but also of diabetes, and cardiovascular disease. [13, 40].
Local and systemic accumulations of pro-inflammatory mediators, such as 
prostaglandins E2, interleukins, tumor necrosis factor α (TNF- α) and metallopro-
teinase (MMP) can stimulate the labor [41]. It is likely that spontaneous preterm 
parturition is induced by a high level of inflammation in the early stage of preg-
nancy [39]. However, the exact role of periodontal inflammation and the potential 
biological mechanisms that link periodontal disease with adverse pregnancy 
outcomes is not fully understood.
4.5 Clinical indications for pregnant women
European Federation of Periodontology guidelines for oral-health professionals 
provides the following recommendations [42]:
• During the examination of the oral status, dental professionals should always 
ask any female patient of childbearing age whether she is pregnant and should 
always consider pregnancy status before recommending any oral-health 
intervention.
• Inform women who are not pregnant of the importance of oral and periodontal 
health during pregnancy and of the treatment of existing periodontal diseases 
before becoming pregnant.
• For any pregnant women, perform a comprehensive clinical periodontal exam-
ination and formulate a diagnosis of “healthy”, “gingivitis”, or “periodontitis”.
• Pregnant women with a healthy periodontium should be provided with 
oral-health education and preventive personal plaque control measures that 
should became healthy habits throughout life. Also, provide information 
on the inflammatory periodontal events that could occur during pregnancy 
(increased gingival bleeding and gingival enlargement).
• Pregnant woman with gingivitis should be provided with the same oral-health 
education and personal plaque control measures, as well as professional 
mechanical instrumentation for removing plaque and calculus deposits from 
the tooth surfaces. The reevaluation of the periodontal status, in terms of effi-
cacy of the professional and personal interventions and periodontal monitor-
ing throughout pregnancy are mandatory.
• Pregnant women with periodontitis should also have the same oral-health 
educational measures, as well as additional professional intervention by means 
of standard non-surgical periodontal therapy (scaling and root planing).
• Non-surgical periodontal therapy, dental treatments and extractions are safe 
during pregnancy, mainly during the second trimester of gestation.
• Local anesthesia, common painkillers and systemic antibiotics are generally 
safe without additional risk to the foetus or the pregnant woman.
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• Tetracyclines should be strictly avoided. Other medication should be pre-
scribed to the pregnant woman after communication with her obstetrician.
• Although EFP recommends dental x-rays and chemical plaque-control 
agents during pregnancy, the authors of the present chapter are not keen to 
recommending them.
5. Implications of periodontitis in oral carcinogenesis
5.1  Epidemiological associations between periodontitis and head and neck 
squamos cell carcinoma
Cancer is one of the leading causes of worldwide mortality. In 2016, 1.1 million 
new cases were reported, and the prevalence was of 4.1 million cases. Head and 
neck squamous cell carcinomas (HNSCCs) constituted 5.7% of global cancer-
related mortality, the equivalent of 512.770 deaths. Also the global mortality burden 
is expected to increase; by 2030 an estimated 705.902 people worldwide will be 
expected to die due to HNSCC [43]. This great burden of cancer worldwide strongly 
indicates the need for implementing rigorous screening and control programs in 
order to facilitate the identification of all potential HNSCC related risk factors, 
including periodontitis, and the early detection of HNSCC.
Squamous cell carcinoma is the most common histological subtype of oral and 
oropharyngeal malignant tumors, accounting for about 90% of the cases. The inci-
dence of HNSCCs are reported to be on the rise, with a global estimated incidence 
of over 300.000 new cases registered each year [44, 45].
Emerging evidence indicates periodontitis as a potential independent risk 
factor for the development of premalignant lesions and HNSCC [46, 47]. Current 
evidence regarding a positive association between periodontitis and oral and 
oropharyngeal cancers are currently controversial [48]. Some studies suggest an 
increased susceptibility to HNSCC in periodontitis patients [49]. Extended and 
severe forms of periodontitis have been frequently identified among patients with 
HNSCC [48].
A meta-analysis reported a 2.66-fold higher risk for oral cancer in patients with 
periodontal disease as compared to periodontal healthy controls [50]. A hospital-
based case-cohort study, after controlling for important confounders, found that 
individuals with periodontitis were 3.7 times more likely to have oral squamous cell 
carcinoma as compared to individuals without periodontitis [51].
Positive associations between periodontitis and other cancers such as diges-
tive tract cancer, pancreatic cancer, prostate cancer, breast cancer, corpus uteri 
cancer, lung cancer, hematological cancer, and Non-Hodgkin lymphoma have been 
reported [46].
The relationship between periodontitis and HNSCC has been reported based on 
the specific periodontal parameters or surrogate markers of periodontal disease. 
An increased risk of HNSCC development, with respect to the number of missing 
teeth has been observed. A 2.7-fold increased risk of oral cancer in patients having 
11 to 16 missing teeth as compared to dentate subjects has been reported [52]. A 
5.23-fold increase in the risk of tongue cancer and a 4-fold increased risk of head 
and neck squamous cell carcinoma for each millimeter of alveolar bone loss, after 
the adjustment for important confounders has been reported [53, 54]. This data 
suggest that the severity and extension of periodontitis might be a risk indicator for 
HNSCC [55].
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5.2 The influence of chronic periodontal inflammation in carcinogenesis
The investigation of the causal role of periodontitis in the cancer development 
is challenging due to the major independent and shared risk factors of these condi-
tions. Periodontitis may have a direct effect on the rise of cancer risk or may impact 
through shared genetic and environmental factors [56]. Smoking is one of the main 
independent risk factors for periodontitis and HNSCC, while smoking and alcohol 
consumptions account for up to 85% of all oral cancers. The synergic effect of 
alcohol and tobacco consumption increases the risk for of oral cancer by 15 times 
[57, 58] However, about 15% to 20% of the HNSCCs occur independently to any of 
these risk factors, and the clinical features and evolution of the cancer in this group 
is often particularly aggressive [57–60].
Some molecular pathogenic mechanism could associate periodontitis to oral 
cancers and are briefly detailed below.
5.2.1 Destruction of epithelial barrier promotes the passage of toxic compounds
Chronic periodontal inflammation might be an extrinsic pathway in cancer 
development [46, 47, 61, 62]. The damage of the junctional epithelium mediated by 
periodontal pathogens alters its protective function promoting the absorption of toxic 
compounds from alcohol and tobacco, which in turn create a chronic inflammatory 
environment [61, 63]. The inflammatory process and the presence of cell-stimulating 
signals may create an optimal environment for the atypical cell proliferation and dif-
ferentiation, which may eventually lead to cancer development [46, 61, 63].
5.2.2 Increased pro-inflammatory periodontal mediators damage DNA
In periodontitis, the complex inflammatory response developed to eliminate 
periodontal pathogens leads to the accumulation of excessive levels of endogenous 
compounds such as cytokines, chemokines, prostaglandins, reactive oxygen and 
nitrogen species, matrix metalloproteinases, and endothelial and epidermal growth 
factors. The anarchic and excessive release of these molecules is responsible for the 
indirect destruction of periodontal tissues [64]. In the meantime, these proinflamma-
tory molecules may irreversibly damage the cellular DNA, deregulate the mechanisms 
of DNA repair and subvert the cell cycle regulatory mechanisms [65, 66]. Thus, 
cumulative, permanent genetic alterations lead to oncogenes activation or tumor 
suppressor genes inactivation [67].
5.2.3  Increased proinflammatory periodontal mediators promote epigenetic 
modifications
Epigenetic changes occur more frequently than gene mutations and may persist 
for the entire cell life and even for multiple generations. Extensive exposure of oral 
mucosa to bacteria and chemokines may contribute to carcinogenesis by causing 
epigenetic alterations. The epigenetic changes, which refer to any heritable modifi-
cations in gene expression without alterations of the DNA sequence, also promote 
genomic instability. Epigenetic mechanisms include DNA methylation, posttrans-
lational modifications of histone proteins and post-transcriptional gene down-
regulation by microRNAs. Any of these three distinct epigenetic mechanisms leads 
to inappropriate gene expression and cancer development [61, 67, 68]. A relatively 
stable epigenetic change may induce the increase of carcinogenesis mechanisms 
such as faster cellular proliferation, stimulation of an increased angiogenesis, and 
inhibition of apoptosis [61].
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The methylation of DNA refers to the covalent addition of a methyl group to 
the 5-carbon position of cytosine base from a CpG dinucleotide. Hypermetilation 
of CpG islands of growth-regulatory genes promoter regions causes the transcrip-
tional “silencing” of tumor suppressor genes and promotes tumor progression [68]. 
Although some aberrant methylation patterns have been already identified, the 
complex underlying molecular mechanisms that address the association of chronic 
periodontal inflammation and oral cancers are still not fully understood [61].
Histones, proteins binding to the DNA in the nucleus and condensing it into 
chromatin, can undergo multiple aberrant post-translational modifications, which 
induce structural and functional modification in the chromatin and thus alterations 
of the pattern of gene expression directly contributing to the initiation of neoplasia 
and its subsequent course [68].
5.2.4 The increased release of pro-inflammatory mediators
The increased release of inflammatory mediators in periodontitis, such as 
interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor–α (TNF–α) 
[61], may trigger epithelial-mesenchymal transition and activation of inflammatory 
cells which facilitate cancer invasion [61, 69].
5.2.5 Increased levels of IL-8 regulate carcinoma growth
IL-8 is primarily produced by periodontal cells in response to periodontal 
bacteria, like Porphyromonas gingivalis, and bacterial toxins [13, 70]. One of the 
possible links between Porphyromonas gingivalis and oral squamous cell carcinoma 
may be the increased IL-8 levels in the periodontal microenvironment and the sub-
sequent overexpression of MMPs. IL-8 has long been recognized as an autocrine 
regulator of oral squamos cell carcinoma growth, and a contributor of increased 
cell motility. Thus, salivary IL-8 has been proposed to be a discriminative diagnos-
tic biomarker for oral cancer detection [69, 70].
5.2.6 The influence of inflammasomes-mediated inflammation in cancer
More recent studies investigated the topic of inflammasome-mediated inflam-
mation in cancer. The inflammasome is a part of the innate immune system and 
it responds to microbial challenge through regulation of caspase-1 activation and 
induction of inflammation. The most studied and best characterized inflam-
masome, Nucleotide-Binding Domain, Leucine-Rich–Containing Family, Pyrin 
Domain–Containing-3 (NLRP3), is an emerging, key player in the development and 
progression of cancer. Activation of NLRP3 may promote inflammation induced 
tumor growth and metastasis in HNSCC [71]. Certain periodontal pathogens, such 
as Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans have the abil-
ity to modulate inflammation and potentially induce carcinogenesis by controlling 
interleukin-1β (IL-1β) secretion through NRLP3 inflammasome complex activated 
by adenosine 5 ‘- triphosphate (ATP). IL-1β is directly involved in several chronic 
pathologies and various types of cancers, including oral cancer [72, 73].
5.2.7 The role of transcription factors
Inflammatory mediators, microbes, as well as environmental factors (tobacco 
and alcohol consumption) could activate some transcription factors, such as the 
nuclear signal transducers and activators of transcription-3 (STAT-3), the activator 
protein-1 (AP-1) and the nuclear factor-kB (NF-kB). These transcription factors 
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activate oncogenes that regulate apoptosis, cell proliferation and angiogenesis as 
well as genes regulating the production of pro-inflammatory molecules. These 
oncogenic changes drive a tumor-promoting inflammatory milieu through the 
intrinsic pathway that favors the development of already established tumors. 
Moreover, the inflammatory microenvironment favors the tumor to escape from 
immune surveillance and alters the response to chemotherapy [65, 66, 74].
5.2.8 Periodontitis associated-oxidative stress promoting carcinogenesis
Oxidative stress occurs as a state of disturbance between free radical produc-
tion and the capability of antioxidant system to counteract the free radicals. The 
activity of periodontal bacteria induces oxidative stress through free radical release, 
and decreased plasma antioxidant capacity. On the other hand, oxidative stress 
causes inflammation, which can increase the production of free radicals. Patients 
with chronic periodontitis showed low serum and salivary antioxidants levels and 
elevated oxidative stress biomarkers such as 8-isoprostane and malondialdehyde. 
Moreover, assessment of blood and gingival tissues of chronic periodontitis patients 
also revealed mitochondrial DNA deletion mediated by lipid peroxidation [73].
Oxidative stress is also correlated to oral cancer. Increased lipid peroxidation and 
reduced antioxidants was reported in patients with oral cancer. Lipid peroxidation 
and irreversible protein modifications are essential molecular mechanisms involved 
in the oxidative damage of cell structures eventually leading to programmed cell 
death [73, 75]. Elevated levels of malondialdehyde and low levels of glutathione 
were observed in the saliva and serum of HNSCC patients [73, 76].
Chronic periodontal inflammation induces a prolonged exposure of oral cells to 
free radicals that can lead to genomic alterations through DNA damage, lipid and 
protein peroxidation and activation of signal transduction by post translational 
modification [66]. Therefore, the accumulation of oxidative stress products in 
periodontal tissues may significantly contribute to the development of oral cancer.
Oncogene and tumor suppressor pathways are proven intracellular targets for 
therapies, but recent scientific data are pointing out to new potential, extracellular 
vesicle-based therapeutic targets such as chemokines and chemokines receptors. 
Anti-inflammatory therapies have been successful in preventing progression and 
even curing some types of infectious agents associated cancers [66, 74]. Hence, 
control of chronic periodontal inflammation through specific periodontal therapy 
could be part of a comprehensive HNSCCs prevention strategy.
5.3 Periodontal bacteria in carciongenesis - Porphyromona gingivalis
Porphyromonas gingivalis is a true periodontal pathogen contributing in devel-
opment of severe chronic inflammations of periodontal tissues. Porphyromonas 
gingivalis has been frequently associate with cancer and the most highly associated 
organism with oral squamous cell carcinomas [72]. Besides colonizing dental sur-
faces, the microorganism is also able to colonize various parts of the oral mucosa, 
which are described to be primary lesion sites during oral squamous cell cancer 
initiation [72].
Porphyromonas gingivalis produces various virulence factors which can modulate 
oral persistent inflammation and thus the complex physio-pathological network 
leading to carcinogenesis [72, 77]. Porphyromonas gingivalis as well as other peri-
odontal microorganisms can trigger the development of a dysbiotic microbhabitat. 
Porphyromonas gingivalis has the capacity of disrupting the periodontal homeostasis 
by promoting the transformation of the commensal microbiota into a pathological 
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one. Also it can modulate the host’s immune system, thus being able to intervene 
directly in the development of cancers at the oral or distant sites [78].
Porphyromonas gingivalis invades oral epithelial cells and could affect cell cycle 
related molecules at different stages [79]. Epithelial cell responses to Porphyromonas 
gingivalis infection include both changes to apoptosis and cell division [72, 77, 79]; 
these mechanisms are characteristic to cancer development and progression.
Porphyromonas gingivalis lipopolysaccharides could deregulate tumor sup-
pressor gene p53 [72, 77]. Gingipains and cysteine proteinases produced by 
Porphyromonas gingivalis, play a key role in activating MMP-9, which degrades 
the basement membrane and the extracellular matrix, promoting carcinoma 
cell migration and invasion, thus allowing dissemination and metastatic 
growth at remote sites [72, 77, 78, 80]. Also in oral squamous cell carcinoma 
cells, Porphyromonas gingivalis stimulates the release of a variety of cytokines, 
including IL-8, which can increase MMP-9 production and cell proliferation and 
invasiveness [80].
Porphyromonas gingivalis can also modulate the expression of microRNAs of the 
epithelial cells, and up-regulation of miR-203 leads to inhibition of the negative regu-
lator suppressor of cytokine signaling 3 and subsequent suppression of apoptosis [77].
Porphyromonas gingivalis secretes a nucleoside diphosphate kinase (NDK) having 
an ATPase function and preventing ATP-dependent apoptosis mediated through the 
purinergic receptor P2X7. Thus, NDK can suppress the proapoptotic and proinflam-
matory mechanisms in oral epithelial cells favoring carcinogenesis [72, 77].
The heat shock protein GroEL is another virulence factor of Porphyromonas 
gingivalis that might have a direct carcinogenic effects on certain oral cancer cell 
lines [72].
Porphyromonas gingivalis can induce the expression of the B7-H1 and B7-DC 
involved in regulating the cell-mediated immune response, but also up-regulated in 
cells originating from a variety of cancers. B7-H1 expression promotes the event of 
regulatory T cells that suppress effector T cells. B7-H1 expression might contribute 
to immune evasion by oral cancers [47, 77, 80].
Currently, among the known virulence molecules of Porphyromonas gingivalis, 
there is not a significantly attributed molecular determinant that could be strongly 
linked to the illustrated association of Porphyromonas gingivalis with orodigestive 
cancers. It is very likely that the potential synergistic ability of Porphyromonas gingi-
valis with other oral microbial species are contributory to the postulated malignant 
transformation and progression in the oral cavity and upper digestive tract [72].
6. Conclusions
Understanding the dynamics and common, underlying pathophysiological 
mechanisms that link periodontitis to systemic diseases is essential to the develop-
ment of coherent, patient centered diagnostic and therapeutic strategies.
An increased risk for preterm birth and low birth weight of newborns in moth-
ers with periodontitis has been reported. Pregnant women should be provided with 
oral-health education and preventive personal plaque control measures that should 
become healthy habits throughout life. Non-surgical periodontal therapy is safe 
during pregnancy, and especially during the second trimester of gestation.
The epigenetic alterations in periodontal disease such as histone acetylation 
and DNA methylation, and the subsequently altered gene expression might par-
tially explain the role of periodontal inflammation in cancer development and 
tumor growth.
Periodontology - Fundamentals and Clinical Features
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